Editorial Comment from Dr Chapple to Long ‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

International Journal of Urology, EarlyView.

Source: International Journal of Urology - June 5, 2018 Category: Urology & Nephrology Authors: Christopher R Chapple B.Sc., M.D., F.R.C.S. (Urol), F.E.B.U. Source Type: research